´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, À¯Çüº°, ¿ëµµº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2024-2031³â)
Single Cell Analysis Market Size, Share, Growth Analysis, By Type(Flow Cytometry, Next-Generation Sequencing ), By Application(Research Applications, Clinical Applications), By Region - Industry Forecast 2024-2031
´ÜÀϼ¼Æ÷ ºÐ¼® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2022³â 32¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2023³â 36¾ï 3,000¸¸ ´Þ·¯¿¡¼ 2031³â 100¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È 13.50%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
´ÜÀϼ¼Æ÷ ºÐ¼® ¼¼°è ½ÃÀåÀº °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, °¡±î¿î ½ÃÀÏ ³»¿¡ ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÐ¾ß´Â ¾Ï ¿¬±¸, ¸é¿ªÇÐ, ½Å°æ°úÇÐ, Áٱ⼼Æ÷ »ý¹°ÇÐ µî ´Ù¾çÇÑ ¿¬±¸ ºÐ¾ß¿¡¼ ±× Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. À¯ÀüüÇÐ ¹× ºÐÀÚ»ý¹°ÇÐÀÇ ¹ßÀüÀº Á¶Á÷°ú »ý¹°Ã¼ ³»ÀÇ °³º° ¼¼Æ÷°¡ ´Ù¾çÇÑ Æ¯Â¡°ú ¹ÝÀÀÀ» º¸ÀÏ ¼ö ÀÖ´Ù´Â Á¡À» ºÎ°¢½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀº Ç¥Àû Ä¡·á¿Í Á¤¹Ð ÀÇÇÐÀ¸·ÎÀÇ ÀüȯÀ» ÃËÁøÇϰí ÀÖÀ¸¸ç, ´ÜÀϼ¼Æ÷¸¦ ºÐ¼®ÇÏ´Â °ÍÀº ȯÀÚ °³°³Àο¡°Ô ¸ÂÃãÈµÈ Ä¡·á¸¦ À§ÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. °³º° ¼¼Æ÷¸¦ °Ë»çÇÒ ¼ö ÀÖ´Â ´É·ÂÀº Áúº´¿¡ Æ¯ÈµÈ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϰí, Áúº´ ÁøÇàÀ» ÀÌÇØÇϸç, È¿°úÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ´ÜÀϼ¼Æ÷ ºÐ¼® ±â¼ú°ú ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯¼¼Æ÷ ºÐ¼®, Â÷¼¼´ë ½ÃÄö½Ì, Áú·® ¼¼Æ÷ ºÐ¼®, ´ÜÀÏ ¼¼Æ÷ PCR°ú °°Àº ±â¼úÀº ¼¼Æ÷ÀÇ Æ¯¼º°ú ±â´ÉÀ» °íÇØ»óµµ·Î ºÐ¼®ÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á ÀÌ ºÐ¾ß¸¦ Çõ½ÅÀûÀ¸·Î º¯È½Ã۰í ÀÖÀ¸¸ç, ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
¼Ò°³
Á¶»ç ¹æ¹ý
- Á¤º¸ Á¶´Þ
- 2Â÷ µ¥ÀÌÅÍ ¼Ò½º¿Í 1Â÷ µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ±Ô¸ð ¿¹Ãø
- ½ÃÀå »óÁ¤°ú Á¦ÇÑ
ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä Àü¸Á
- °ø±Þ ¼ö¿ä µ¿Ç⠺м®
- ºÎ¹®º° ±âȸ ºÐ¼®
½ÃÀå ¿ªÇаú Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- °úÁ¦
- Porters ºÐ¼®
ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®
- ±â¼ú ºÐ¼®
- °¡°Ý ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ½ÃÀå »ýŰè
- ¹«¿ª ºÐ¼®
- °ø±Þ¸Á ºÐ¼®
- »ç·Ê ¿¬±¸ ºÐ¼®
- ƯÇ㠺м®
- °í°´°ú ±¸¸Å ±âÁØ ºÐ¼®
- ±ÔÁ¦ »óȲ
- Çõ½Å ¸ÅÆ®¸¯½º
- ÁÖ¿ä ÅõÀÚ ºÐ¼®
- ÁÖ¿ä ¼º°ø¿äÀÎ
- °æÀï Á¤µµ
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : Á¦Ç°º°
- ½ÃÀå °³¿ä
- ¼Ò¸ðǰ
- ºñÁî, ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ®
- ½Ã¾à
- ¾î¼¼ÀÌ Å°Æ®
- ¸é¿ªÃøÁ¤
- ¼¼Æ÷ ±â¹Ý ¾î¼¼ÀÌ
- ±âŸ ¼Ò¸ðǰ
- ±â±â
- À¯¼¼Æ÷ ºÐ¼®±â
- NGS ½Ã½ºÅÛ
- PCR ±â±â
- ºÐ±¤±¤µµ°è
- ¼¼Æ÷ Ä«¿îÅÍ
- Çö¹Ì°æ
- HCS ½Ã½ºÅÛ
- ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
- ±âŸ ±â±â
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ¼¼Æ÷ À¯Çüº°
- ½ÃÀå °³¿ä
- Àΰ£ ¼¼Æ÷
- µ¿¹° ¼¼Æ÷
- ¹Ì»ý¹° ¼¼Æ÷
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ¹æ¹ýº°
- ½ÃÀå °³¿ä
- À¯¼¼Æ÷ ºÐ¼®
- Â÷¼¼´ë ½ÃÄö½Ì
- ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
- Çö¹Ì°æ °Ë»ç
- Áú·® ºÐ¼®
- ±âŸ ¹æ¹ý
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ¿ëµµº°
- ½ÃÀå °³¿ä
- ¿¬±¸ ¿ëµµ
- ¾Ï ¿¬±¸
- ¸é¿ªÇÐ ¿¬±¸
- ½Å°æÇÐ ¿¬±¸
- Áٱ⼼Æ÷ ¿¬±¸
- ±âŸ ¿¬±¸ ¿ëµµ
- ÀÇ·á ¿ëµµ
- ºñħ½ÀÀû »êÀü Áø´Ü
- ü¿Ü¼öÁ¤
- ¼øÈ¯Á¾¾ç¼¼Æ÷ °ËÃâ
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå °³¿ä
- Çмú¿¬±¸±â°ü
- ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾àȸ»ç
- º´¿ø ¹× Áø´Ü ¿¬±¸¼Ò
- ¼¼Æ÷ÀºÇà°ú ü¿Ü¼öÁ¤ ¼¾ÅÍ
´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå ±Ô¸ð : Áö¿ªº°
- ½ÃÀå °³¿ä
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
- GCC ±¹°¡
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°æÀï »óȲ
- »óÀ§ 5°³»çÀÇ ºñ±³
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
- ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤¿ëÇÑ Àü·«
- ½ÃÀåÀÇ Ãֱ٠Ȱµ¿
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2023³â)
ÁÖ¿ä ±â¾÷ °³¿ä
- BD(US)
- Thermo Fisher Scientific Inc.(US)
- Danaher Corporation(US)
- 10x Genomics(US)
- Merck KGaA(Germany)
- Agilent Technologies, Inc.(US)
- Qiagen(Germany)
- Illumina, Inc.(US)
- Bio-Rad Laboratories, Inc.(US)
- Diasorin S.P.A.(Italy)
- Standard Biotools(US)
- Tecan Trading AG(Switzerland)
- Sartorius AG(Germany)
- Corning Incorporated(US)
- Cytek Biosciences(US)
- Takara Bio Inc.(Japan)
- Biomerieux(France)
- Revvity(US)
- Bio-Techne(US)
- Pacbio(US)
- Bruker(US)
- Promega Corporation(US)
- Oxford Nanopore Technologies Plc(UK)
- Singleron Biotechnologies(China)
- Cell Microsystems(US)
- Nanocellect Biomedical(US)
- Rarecyte, Inc.(US)
- Bico(Sweden)
- Menarini Group(Italy)
ksm
Global Single Cell Analysis Market size was valued at USD 3.20 billion in 2022 and is poised to grow from USD 3.63 billion in 2023 to USD 10.00 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).
The global market for single-cell analysis is experiencing robust growth and is set for further expansion in the near future. This field is becoming increasingly significant across various research areas including cancer research, immunology, neuroscience, and stem cell biology. A major driver of this growth is the rising demand for personalized medicine. Advances in genomics and molecular biology have highlighted that individual cells within a tissue or organism can display a range of distinct characteristics and responses. This realization is pushing the shift towards targeted therapies and precision medicine, where analyzing single cells provides critical insights for customizing treatments to individual patients. The ability to examine individual cells has been instrumental in identifying disease-specific biomarkers, understanding disease progression, and developing effective therapies. As a result, there is a growing market demand for single-cell analysis technologies and solutions. Techniques such as flow cytometry, next-generation sequencing, mass cytometry, and single-cell PCR have transformed the field by enabling high-resolution analysis of cellular characteristics and functions, further fueling market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Single Cell Analysis Market Segmental Analysis
Global Single Cell Analysis Market is segmented by Product, Cell Type, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, Animal Cells, and Microbial Cells. Based on Technique, the market is segmented into Flow Cytometry, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, and Other Techniques. Based on Application, the market is segmented into Research Applications, Medical Applications. Based on End User, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Drivers of the Global Single Cell Analysis Market
Stem cell biology is undergoing a major research boost due to the promising therapeutic potential of stem cells. Single-cell analysis is crucial in this field as it allows for the detailed characterization and manipulation of stem cells at the individual cell level. This approach enables researchers to identify and isolate specific stem cell populations, monitor their differentiation processes, and assess their functional attributes. As interest in stem cell biology grows, there is an increasing demand for sophisticated single-cell analysis tools and technologies to support these advancements.
Restraints in the Global Single Cell Analysis Market
Single-cell analysis faces significant challenges due to its inherent complexity and high costs. The techniques involved often demand specialized equipment, skilled operators, and meticulously defined workflows, which can complicate their implementation. This complexity can limit the widespread adoption of single-cell analysis, especially in resource-constrained environments where advanced infrastructure and expertise are scarce. Additionally, the financial burden associated with acquiring and maintaining the necessary equipment and reagents for single-cell analysis can be prohibitive for smaller research labs and institutions. These cost and complexity issues create barriers that need to be addressed to make single-cell analysis more accessible and affordable across diverse research settings.
Market Trends of the Global Single Cell Analysis Market
A notable trend in the single-cell analysis market is the growing adoption of spatial transcriptomics. This advanced technique enables researchers to visualize and analyze gene expression patterns across entire tissues, providing valuable insights into cellular organization. By mapping gene activity in situ, spatial transcriptomics helps identify various cell types and subtypes, as well as elucidate cellular interactions within their native environments. This approach enhances our understanding of tissue architecture and cellular dynamics, offering a deeper perspective on how cells communicate and function collectively. As a result, spatial transcriptomics is becoming increasingly integral to research efforts aimed at unraveling complex biological processes and disease mechanisms.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Value Chain Analysis
- Ecosystem of the Market
- Trade Analysis
- Supply chain Analysis
- Case study Analysis
- Patent Analysis
- Customer & Buying Criteria Analysis
- Regulatory Landscape
- Innovation Matrix
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Single Cell Analysis Market by Product
- Market Overview
- Consumables
- Beads, Microplates
- Reagents
- Assay Kits
- Immunoassays
- Cell-Based Assays
- Other Consumables
- Instruments
- Flow Cytometers
- NGS Systems
- PCR Instruments
- Spectrophotometers
- Cell Counters
- Microscopes
- HCS Systems
- Microarrays
- Other Instruments
Single Cell Analysis Market by Cell Type
- Market Overview
- Human Cells
- Animal Cells
- Microbial Cells
Single Cell Analysis Market by Technique
- Market Overview
- Flow Cytometry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Other Techniques
Single Cell Analysis Market by Application
- Market Overview
- Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
- Medical Applications
- Non-Invasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Single Cell Analysis Market by End User
- Market Overview
- Academic & Research Laboratories
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Cell Banks & IVF Centers
Single Cell Analysis Market Size by Region
- Market Overview
- North America
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- BD (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 10x Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diasorin S.P.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Standard Biotools (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tecan Trading AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cytek Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pacbio (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bruker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Singleron Biotechnologies (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Microsystems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanocellect Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rarecyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bico (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Menarini Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments